Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Royal Brompton & Harefield NHS Foundation Trust | OTHER |
Not provided
Not provided
Not provided
Not provided
This project will use data obtained from a proprietary vision-based patient monitoring and management system (OxeVision) for measuring heart rate and respiratory rate which is in clinical use at the Coventry and Warwickshire Partnership NHS Trust.
The investigators will analyse data from patients with known COVID 19 infection both during, and where possible before clinical COVID 19 infection and controls to determine whether changes can be detected in these parameters that precede overt clinical deterioration. The role of remote vision-based patient monitoring and management in supporting the care of patients with COVID-19 will be assessed through staff interviews.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Participants with COVID 19 diagnosis | We will measure the breathing rate (BR) before and after the clinical diagnosis of COVID 19. |
| |
| Participants without COVID 19 diagnosis | Breathing rates will be measured for the same time duration as the cases. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Observation of breathing pattern | Other | Observations will be collected using a remote vision based patient monitoring and management system. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Breathing rates | Breathing rates collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System. | Data will be collected throughout study completion, an average of 7 months, to obtain breathing rate before and after the diagnosis of COVID 19. |
| Measure | Description | Time Frame |
|---|---|---|
| Pulse rates | Pulse rate collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System. | Data will be collected throughout study completion, an average of 7 months, to obtain pulse rate before and after the diagnosis of COVID 19. |
| BR and PR |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Children will be excluded. No data will be excluded unless specifically requested by the treating clinician.
Not provided
Not provided
Not provided
Adult participants admitted to inpatient mental health wards.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael Polkey | The Royal Bromptom Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Coventry and Warwickshire Partnership NHS | Coventry | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012120 | Respiration Disorders |
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D012140 | Respiratory Tract Diseases |
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Similar data to be collected from control subjects |
| Data will be collected throughout study completion, an average of 7 months, to obtain breathing and pulse rate before and after the diagnosis of COVID 19. |
| D007239 |
| Infections |
| D014777 | Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |